NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 109 filers reported holding NEVRO CORP in Q3 2015. The put-call ratio across all filers is 0.37 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $56,625,000 | -22.5% | 779,315 | +11.3% | 0.01% | -33.3% |
| Q3 2016 | $73,075,000 | +53.2% | 700,023 | +8.2% | 0.02% | +36.4% |
| Q2 2016 | $47,706,000 | +90.4% | 646,769 | +45.3% | 0.01% | +83.3% |
| Q1 2016 | $25,051,000 | -18.0% | 445,266 | -1.6% | 0.01% | -14.3% |
| Q4 2015 | $30,533,000 | +52.3% | 452,278 | +4.6% | 0.01% | +40.0% |
| Q3 2015 | $20,049,000 | -10.2% | 432,185 | +4.1% | 0.01% | 0.0% |
| Q2 2015 | $22,321,000 | +108.1% | 415,274 | +85.5% | 0.01% | +66.7% |
| Q1 2015 | $10,728,000 | +25.6% | 223,835 | +1.3% | 0.00% | +50.0% |
| Q4 2014 | $8,543,000 | – | 220,921 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |